Cortical blindness

disease
On this page

Also known as cerebral visual impairmentcortical visual impairmentcortical/cerebral visual impairmentCVI

Summary

Cortical blindness (MONDO:0001385) is a disease and 19 clinical trials. A subtype of blindness (disorder) — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 19

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namecortical blindness
Mondo IDMONDO:0001385
MeSHD019575
DOIDDOID:11831
ICD-10-CMH47.61
NCITC118707
SNOMED CT68574006
UMLSC0155320
MedGen57834
GARD0027575
Is cancer (heuristic)no

Also known as: cerebral visual impairment · cortical visual impairment · cortical/cerebral visual impairment · CVI

Disease family

This is a subtype of blindness (disorder). Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorderperceptual disordersvision disorderblindness (disorder)cortical blindness

Related subtypes (3): night blindness, microcephaly microphthalmos blindness, amaurosis fugax

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 19.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified19

Top trials by phase / activity

NCTPhaseStatusTitle
NCT05085210Not specifiedRECRUITINGImproving Visual Field Deficits With Noninvasive Brain Stimulation
NCT06121219Not specifiedRECRUITINGEffect of Visual Retraining After Stroke
NCT06636994Not specifiedACTIVE_NOT_RECRUITINGAnatomical and Functional Predictions of Blindsight Capabilities in Patients With Lateral Hemianopsia
NCT06701617Not specifiedRECRUITINGIn-person and Telehealth Visual Rehabilitation for Children With Low Vision
NCT07105358Not specifiedRECRUITINGVisual Plasticity Following Brain Lesions
NCT07134777Not specifiedRECRUITINGMechanisms of Visual Restoration After Occipital Stroke
NCT07212010Not specifiedENROLLING_BY_INVITATIONNeurodevelopmental Outcomes in Cerebral Visual Impairment
NCT07427719Not specifiedNOT_YET_RECRUITINGRetinopathy of Prematurity - Visual Function and Retinal Structure
NCT00342108Not specifiedCOMPLETEDCortical Visual Impairment and Visual Attentiveness
NCT03957980Not specifiedCOMPLETEDRemote Access: Cortical Visual Impairment
NCT04051983Not specifiedCOMPLETEDiVision - Development of a Game-based Therapy for Children With Cerebral Visual Impairment
NCT05014503Not specifiedCOMPLETEDA Computerized, Adaptive Therapeutic Gaming Approach Training Visual Perceptual Skills in Children With CVI
NCT05048550Not specifiedUNKNOWNBabies in Glasses; a Feasibility Study.
NCT05102955Not specifiedCOMPLETEDTurkish Validity and Reliability of the Visual Function Classification System (VFCS)
NCT06067607Not specifiedUNKNOWNExamining the Effect of Eye Gaze Technology on Children With Cortical Visual Impairment
NCT06352086Not specifiedWITHDRAWNUnderstanding Visual Processing After Occipital Stroke
NCT06599996Not specifiedCOMPLETEDArtificial Intelligence and Augmentative and Alternative Communication AAC
NCT06827743Not specifiedCOMPLETEDFeeding Behavior Intervention in Children with Cerebral Visual Impairment
NCT07492966Not specifiedCOMPLETEDExosomes Effect on Visual Function in CVI

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.